Shouxiangu(SH:603896)2021-09-06 08:49Group 1: Event Overview - The half-year performance briefing and investor reception event was held on September 16, 2021, to enhance corporate governance and communication with investors [2] - The event took place at two locations: the organic medicinal herb planting base in Wuyi County in the morning and the company headquarters in the afternoon [3] - A total of 45 investors attended the event, with key company personnel including Chairman and General Manager Li Mingyan and other executives present [3] Group 2: Activity Schedule - The schedule included a visit to the organic medicinal herb planting base from 10:30 to 11:30 and a visit to the company headquarters from 13:00 to 14:30 [4] - The afternoon session featured a performance report by the Secretary of the Board, Liu Guofang, and a presentation on the national promotion strategy by Li Zhenyu, General Manager of Jishi Health Development Co., Ltd. [4] Group 3: Sales and Marketing Strategies - The company plans to adopt a new sales model by recruiting regional distributors to enhance sales through established channels [5] - A diverse product range is available to cater to different consumer demographics, including high-end and low-end products [6] - Increased advertising expenses in the first half of the year were attributed to heightened promotional activities [7] Group 4: Price Control Measures - The company implements several measures to maintain its product pricing structure, including anti-counterfeiting codes and regular market price checks [7][8] - A dedicated pricing control team monitors both online and offline markets to ensure compliance with pricing agreements [8] Group 5: Future Brand Promotion - Future advertising strategies will align with distributor promotion tactics, utilizing both national and local advertising channels [9] - The company emphasizes the importance of building customer trust through distributor resources, especially for high-priced products like the Lingzhi spore powder tablets [9] Group 6: Shareholder Actions - The company has repurchased 3.58 million shares, primarily for sales and management team equity incentives [10] - Investors are advised to refer to publicly disclosed information regarding major shareholder reduction plans [10]